Frontier Rounds— AI funding intelligence

Accurx Funding History

Accurx builds clinical communication software for UK general practices. Its AI scribe writes notes with SNOMED codes into EMIS and SystmOne.

Company Overview

Accurx logo

Accurx

  • Clinical Documentation / Medical Scribe

London, UK

Official Website

Accurx Funding Timeline

  1. Announced Sep 15, 2021

    Series B

    GBP 27.5 million

    Accurx planned to use the financing to expand its team, improve its tools for GP practices and develop products for secondary care.

    Led by Lakestar. Participation included Atomico.

    Source · british-business-bank.co.uk ↗

  2. Announced Feb 24, 2019

    Series A

    GBP 8.8 million

    The funding backed Accurx’s messaging tools for GP practices and patients. TechCrunch reported that the investment appeared to have closed the previous week.

    Led by Atomico.

    Source · techcrunch.com ↗

Accurx Founding Team

Jacob Haddad and Laurence Bargery started Accurx to tackle antimicrobial resistance. After observing how staff worked in general practices, they shifted the company’s focus to communication among clinicians and patients.

Accurx Products

  • Accurx Scribe

    Capture a consultation and draft a coded note for the patient's record.

Accurx Company Development

Clinical Documentation Joins the Messaging Workflow

Accurx extended its GP communication software into visit documentation. The scribe writes SNOMED-coded notes into EMIS and SystmOne, putting the new workflow inside the systems where practices already keep their records.

Accurx Competitive Landscape

Where the Notes Need to Land

Accurx and Freed address the time clinicians spend documenting visits. Accurx’s named integrations and SNOMED coding are particularly relevant to UK GP practices, while Freed’s offering is organized around documenting visits and transferring notes to supported EHRs.